前往化源商城

Pharmacology 2008-01-01

CRTH2 is not involved in the anti-enteropooling effect of PGD2 in the small intestine.

C Prenn, A Heinemann, R Schuligoi, B A Peskar

文献索引:Pharmacology 81(3) , 236-40, (2008)

全文:HTML全文

摘要

The majority of prostaglandins (PGs) are known to induce intestinal fluid secretion (enteropooling). In contrast, PGD(2) has been demonstrated to inhibit fluid secretion induced by other PGs. This study was aimed to investigate, by the use of selective agonists/antagonists, which type of PGD(2) receptor mediates this inhibitory effect. The DP1 agonist BW245C dose-dependently inhibited the enteropooling effect of 16,16-dimethyl-PGE(2). This inhibition was counteracted by the DP1 antagonist BWA868C. In contrast, the CRTH2 receptor does not seem to be involved in the anti-enteropooling effect of PGD(2), since the selective agonists 13,14-dihydro-15-keto-PGD(2) and 15(R)-15-methyl-PGD(2) were without effect. Therefore, our results suggest that the inhibitory effect of PGD(2) in the small intestine is mediated via activation of the DP1 receptor.Copyright 2008 S. Karger AG, Basel.

相关化合物

结构式 名称/CAS号 全部文献
16,16-Dimethyl prostaglandin E2 结构式 16,16-Dimethyl prostaglandin E2
CAS:39746-25-3
BW 245C 结构式 BW 245C
CAS:72814-32-5
3-[(2-环己基-2-羟乙基)氨基]-2,5-二氧代-1-(苯甲基)-4-咪唑啶庚酸 结构式 3-[(2-环己基-2-羟乙基)氨基]-2,5-二氧代-1-(苯甲基)-4-咪唑啶庚酸
CAS:118675-50-6